Sangamo Therapeutics, Inc.SGMONASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-312.74%
↓ 90% vs avg
Percentile
P13
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-164.82%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -312.74% | -102.9% |
| 2024 | -154.13% | -180.6% |
| 2023 | -54.93% | +67.7% |
| 2022 | -169.97% | -13.6% |
| 2021 | -149.68% | -42.8% |
| 2020 | -104.80% | -6.0% |
| 2019 | -98.85% | -11.6% |
| 2018 | -88.56% | +41.0% |
| 2017 | -150.03% | +58.8% |
| 2016 | -364.51% | - |